These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 4743883

  • 1. Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis.
    Chase TN, Holden EM, Brody JA.
    Arch Neurol; 1973 Nov; 29(5):328-33. PubMed ID: 4743883
    [No Abstract] [Full Text] [Related]

  • 2. Levodopa and adventitious movements.
    Lieberman AN, Pedersen B.
    Lancet; 1970 Nov 07; 2(7680):985. PubMed ID: 4097634
    [No Abstract] [Full Text] [Related]

  • 3. Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine.
    Holden EM, Brody JA, Chase TN.
    Neurology; 1974 Mar 07; 24(3):263-5. PubMed ID: 4855953
    [No Abstract] [Full Text] [Related]

  • 4. M.I.F.: effect on levodopa dyskinesias in man.
    Woods AC, Chase TN.
    Lancet; 1973 Sep 01; 2(7827):513. PubMed ID: 4125041
    [No Abstract] [Full Text] [Related]

  • 5. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ, Somerville B.
    Med J Aust; 1974 Mar 23; 1(12):429-32. PubMed ID: 4598384
    [No Abstract] [Full Text] [Related]

  • 6. "On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
    Fahn S.
    Neurology; 1974 May 23; 24(5):431-41. PubMed ID: 4857104
    [No Abstract] [Full Text] [Related]

  • 7. Treatment failures with levodopa in Parkinsonism.
    Lieberman AN, Goodgold AL, Goldstein M.
    Neurology; 1972 Nov 23; 22(11):1205-10. PubMed ID: 4673563
    [No Abstract] [Full Text] [Related]

  • 8. Start hesitation--a side effect of long-term levodopa therapy.
    Ambani LM, Van Woert MH.
    N Engl J Med; 1973 May 24; 288(21):1113-5. PubMed ID: 4697941
    [No Abstract] [Full Text] [Related]

  • 9. Levodopa and parkinsonism: clinical impressions.
    Yahr MD.
    Clin Pharmacol Ther; 1971 May 24; 12(2):332-4. PubMed ID: 5577481
    [No Abstract] [Full Text] [Related]

  • 10. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH.
    Neurology; 1970 Dec 24; 20(12):31-5. PubMed ID: 4924342
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of parkinsonism with levodopa.
    Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM.
    Arch Neurol; 1969 Oct 24; 21(4):343-54. PubMed ID: 5820999
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.
    Klawans HL, Weiner WJ.
    J Neurol Neurosurg Psychiatry; 1974 Apr 24; 37(4):427-30. PubMed ID: 4838914
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Levodopa in Parkinsonism.
    Weiss JL, Chase TN.
    Drugs; 1971 Apr 24; 2(4):257-61. PubMed ID: 4948349
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.